Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Mesothelioma, Malignant × Mitomycin × 1 year × Clear all

Sponsor

Conditions

Urinary Bladder Neoplasms 10 Non-Muscle Invasive Bladder Neoplasms 9 Anus Neoplasms 6 Colorectal Neoplasms 5 Appendiceal Neoplasms 5 Peritoneal Neoplasms 4 Carcinoma, Transitional Cell 3 Stomach Neoplasms 2 Pseudomyxoma Peritonei 2 Ovarian Neoplasms 2 Uterine Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Recurrence 1 Rectal Neoplasms 1 Pleural Neoplasms 1 Neoplasm Metastasis 1 Necrosis 1 Nasopharyngeal Carcinoma 1 Mediastinal Neoplasms 1 Lung Metastases 1 Locally Advanced Anal Canal Cancer 1 Liver Neoplasms 1 HIV Infections 1 Gastrointestinal Neoplasms 1 Epstein-Barr Virus Infections 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Carcinoma in Situ 1

Interventions

Cisplatin 15 Pemetrexed 12 pembrolizumab 8 Nivolumab 8 Carboplatin 7 Ipilimumab 5 Cyclophosphamide 5 Platinum 4 1,2-diaminocyclohexaneplatinum II citrate 4 Gemcitabine 3 Drug Therapy 3 tremelimumab 2 fludarabine 2 durvalumab 2 atezolizumab 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Radiation 2 Photochemotherapy 2 Methotrexate 2 Interleukin-2 2 Chemotherapy, Adjuvant 2 sargramostim 1 olaparib 1 niraparib 1 nintedanib 1 methoxyamine 1 lenvatinib 1 enzalutamide 1 decitabine and cedazuridine drug combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡